Cold Case Files:
The Brain's Embedded Evidence
Automated nuclei extraction from archived brain tissue for single-cell genomics. When decades of irreplaceable postmortem data sit locked in paraffin, every section is a case worth solving.
Download PDF VersionTable of contents
The cold
case problem
Somewhere in a hospital basement or a biobank freezer, there is a paraffin block with your patient’s name on it. That block holds decades of clinical history: treatment records, disease progression data, and the molecular signatures of a brain that can never be biopsied again.
Alzheimer’s cohorts followed for twenty years. Glioblastoma resections from surgeries performed last month. Longitudinal aging studies with tissue from patients who have since died. Every one of these FFPE sections is a cold case waiting to be reopened with modern genomic tools.
The tissue is there. The sequencing technology is ready. The missing piece is getting quality nuclei out without destroying what you came to find.
What manual processing
Deparaffinization method
How current
methods
handle
brain FFPE
Three approaches exist for extracting nuclei from FFPE brain tissue. Each makes a different trade-off between cost, effort, and what you get back.
Manual protocols are published and free. Semi-automated systems handle some of the mechanical disruption. The Singulator 200+ automates the entire process, including deparaffinization, with a proprietary safe solvent that eliminates the need for a fume hood.
Why brain tissue is different
Brain tissue is roughly 50% lipid by dry weight. Myelin sheaths generate debris that contaminates nuclei suspensions. Neuronal nuclei are among the most fragile cell populations in any tissue type. These problems compound during manual processing.
Where the
evidence gets
destroyed
Manual and semi-automated FFPE processing fail brain tissue in three specific ways:
1. Fragile neuronal nuclei break during trituration
Harsh manual pipetting destroys the neurons you need most. Robust immune cells survive while fragile attached populations are lost, skewing your data toward cell types that tolerate rough handling.
2. Deparaffinization timing drifts
Twenty minutes or twelve hours, depending on whether someone remembered to check. This single step is the largest source of batch effects in FFPE processing. One operator leaves the sample in xylene overnight; another pulls it early. Same protocol, different results.
3. Myelin and lipid debris contaminate the suspension
Brain tissue produces more lipid debris than any other tissue type. Without built-in filtration, nuclei suspensions become a mixture of intact nuclei, cell ghosts, and micromolecular debris.
Replicate variability
The two-cartridge workflow
The Singulator 200+ uses two cartridges in sequence. The GREEN cartridge handles deparaffinization with a proprietary safe solvent, eliminating xylene and the fume hood entirely. The YELLOW NIC+ cartridge then isolates nuclei through controlled mechanical and enzymatic processing.
Total hands-on time is less than 5 minutes. The instrument handles everything else, including built-in filtration that reduces the myelin and lipid debris specific to brain tissue.
Why automation changes the math
When your input is a single 50-micrometer curl from a postmortem brain section, the processing method determines the outcome. Manual protocols lose 50 to 60 percent of that material before sequencing begins.
The Singulator 200+ consistently recovers over 1 million nuclei from a single curl. The gentle cartridge-based processing preserves fragile neuronal nuclei that manual trituration destroys.
⸻ What changes
- 81% reduction in hands-on time vs. semi-automated methods
- 86% reduction in pipetting steps (4 vs. 28)
- No xylene, no CitriSolv, no fume hood
- Processes inputs as small as 2 mg of tissue
- Built-in filters for myelin and lipid debris
⚠ The irreplaceable sample problem
A failed manual prep on a twenty-year Alzheimer’s cohort section is not a reagent cost. It is the permanent loss of decades of clinical data that cannot be re-collected.
The question is not whether your current protocol works. It is how much of your precious sample it costs you every time.
○ Neurodegenerative disease research
Alzheimer’s, Parkinson’s, and Lewy body dementia cohorts with postmortem brain tissue. Pair snRNA-seq with spatial transcriptomics to map disease pathology at single-cell resolution across longitudinal cohorts.
⚗ Brain tumor biology
Glioblastoma and astrocytoma surgical resections. Capture the complete tumor microenvironment, including cancer cells, immune infiltrate, and stromal populations that manual methods lose to immune cell skew.
♦ Brain atlasing and consortia
BRAIN Initiative, Human Cell Atlas, and multi-site neurodegeneration programs requiring standardized processing across institutions. Operator-independent results eliminate cross-site batch effects.
What your
data is
missing
The brain is the most complex organ in the body, with dozens of cell types organized in architectures that determine function, disease, and behavior. Understanding that complexity requires more than one analytical perspective.
Singulator 200+ nuclei are validated for 10x Flex and PERFF-seq, with snRNA-seq data serving as companion to Xenium spatial analysis. The Dana Pe’er lab at Memorial Sloan Kettering used snRNA-seq from S200+ FFPE nuclei as companion data alongside Xenium spatial analysis on adjacent sections for brain melanoma metastasis mapping. Stanford and MSKCC validated PERFF-seq for rare cell capture from FFPE sections.
☑ Platform-agnostic nuclei
Design your analytical strategy based on your science, not your sample prep. Pair snRNA-seq with spatial on adjacent sections from the same brain. Run PERFF-seq for rare cell populations. The nuclei work with whatever chemistry you choose.
The evidence
recovered
The difference between the Singulator 200+ and manual methods is not speed. It is what comes through intact on the other side.
◉ Cell-type preservation
In a PDAC FFPE study, the Singulator 200+ enriched for fragile cell types including ductal cancer cells and cancer-associated fibroblasts. Semi-automated methods skewed toward neutrophils, missing the populations that drive tumor biology.
◉ Cleaner suspensions
1% erythrocyte contamination compared to 5% with semi-automated approaches. Fewer wasted sequencing reads on contaminants means more of your data reflects actual biology.
∿ Consistent yields
Replicate consistency of 1.0M/1.0M nuclei compared to 1.5M/0.4M with semi-automated methods. A 3.75-fold improvement in reproducibility that matters when samples cannot be replaced.
Performance metrics
Key takeaways
What to consider when processing FFPE brain tissue for single-nuclei genomics.
Treat every section as the last one
Postmortem brain tissue cannot be re-collected. Choose a processing method that maximizes what you recover from each irreplaceable section, not one that is simply familiar.
Measure what manual methods lose
50 to 60 percent sample loss and immune cell skew are not minor inconveniences. They are systematic biases that distort your understanding of brain tissue biology.
Remove the operator from the equation
For longitudinal studies and multi-site consortia, the instrument needs to be the constant. Automated processing with 4 pipetting steps leaves almost nothing for human variability to affect.
Plan for multi-omic integration
The field is moving toward paired spatial and snRNA-seq from the same tissue. Platform-agnostic nuclei let you design the experiment around the science, not the sample prep.
Address brain-specific challenges
Myelin debris, lipid contamination, and fragile neuronal nuclei are not generic FFPE problems. They require built-in filtration and gentle mechanical processing designed for neural tissue.
Eliminate the fume hood bottleneck
A proprietary safe solvent replaces xylene deparaffinization entirely. Any bench becomes a processing station, removing the infrastructure barrier for labs without dedicated chemical hoods.
One shot.
Make it count
on your tissue
Bring your most challenging FFPE brain section. The one from the oldest block, or the one you have been hesitant to process manually. See how the Singulator 200+ handles your tissue, your fixation conditions, your downstream platform.
Talk to a specialist about a sample evaluation with your own material.
Request a Quote
© 2026 Precision Cell Systems. All rights reserved.